For example, a 2011 study in rats found that the peptide successfully healed various lesions and promoted healthy weight gain in models of short-bowel syndrome.14 Additionally, as researchers note in the aforementioned 2016 review on BPC-157 and the gut-brain axis, BPC 157 was successful in the therapy of GI tract, periodontitis, liver and pancreas lesions, and in the healing of various tissues and wounds. Its also written in the review that the peptide acts as a mediator of Roberts cytoprotection, defined as the counteraction of the lesions arising from direct detrimental contact with a noxious agent.7 15 Insider Tip: Though there has been some small-scale positive human research on BPC-157, most of the peptides potential uses are based on the outcomes of animal or cell studies
When timed correctly, 5-Amino-1MQ preloads the cellular NAD+ pool, and MOTS-c administered 46 hours later has the cofactor availability to fully activate AMPK-dependent pathways
Dias I, Costa RGA,Rodrigues A, Silva SLR,Oliveira MS,Soares MBP,Dias RB, Valverde LF, Gurgel Rocha CA
7d and Supplementary Fig
A.KirchnerM.PlckebaumN.SelichA.SerreroM.et al
A different injection site can be used at each visit to offer relief